Press Releases

All Releases
View Summary Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium
Apr 1, 2014
PDF 13.4 KB Add to Briefcase
View Summary Tekmira Announces Completion of Underwritten Public Offering of Common Stock
Mar 18, 2014
PDF 12.6 KB Add to Briefcase
View Summary Tekmira Announces Pricing of Underwritten Public Offering of Common Stock
Mar 13, 2014
PDF 12.6 KB Add to Briefcase
View Summary Tekmira Announces Proposed Public Offering of Common Stock
Mar 10, 2014
PDF 12.7 KB Add to Briefcase
View Summary Tekmira Provides Corporate Update and Announces Year-End 2013 Results
Mar 6, 2014
PDF 19.4 KB Add to Briefcase
View Summary Tekmira Receives Fast Track Designation From FDA for Its Anti-Ebola Viral Therapeutic
Mar 5, 2014
PDF 14.2 KB Add to Briefcase
View Summary Tekmira Conference Call and Webcast Advisory: Corporate Update and 2013 Year-End Financial Results
Mar 4, 2014
PDF 7.5 KB Add to Briefcase
View Summary Tekmira Presents Recent Advances in mRNA Delivery at Scientific Symposium
Feb 25, 2014
PDF 14.6 KB Add to Briefcase
View Summary Tekmira Announces Filing of Shelf Prospectus and Registration Statement
Feb 21, 2014
PDF 12.4 KB Add to Briefcase
View Summary Webcast Advisory: Tekmira to Present at the 2014 RBC Capital Markets' Global Healthcare Conference
Feb 20, 2014
PDF 7.1 KB Add to Briefcase
View Summary Tekmira Announces New Appointment to Board of Directors
Feb 12, 2014
PDF 11.3 KB Add to Briefcase
View Summary Tekmira to Present at the 16th Annual BIO CEO & Investor Conference
Feb 5, 2014
PDF 7.1 KB Add to Briefcase
View Summary Tekmira Receives US$14.5 Million Milestone Payment
Jan 21, 2014
PDF 9.5 KB Add to Briefcase
View Summary Tekmira Doses First Subject in Human Clinical Trial of TKM-Ebola
Jan 14, 2014
PDF 13.0 KB Add to Briefcase
View Summary Tekmira Signs Development Agreement on Delivery Technology for Agricultural Applications
Jan 13, 2014
PDF 12.5 KB Add to Briefcase
View Summary Tekmira Announces Strategic Reorganization to Strengthen Leadership Team
Jan 6, 2014
PDF 12.7 KB Add to Briefcase
View Summary Tekmira Receives $5 Million Milestone Payment for Phase III Initiation of LNP-Enabled Patisiran (ALN-TTR02)
Dec 16, 2013
PDF 11.9 KB Add to Briefcase
View Summary Tekmira's Anti-Ebola Program to Proceed in Clinical Study With More Potent Formulation
Dec 13, 2013
PDF 13.7 KB Add to Briefcase
View Summary Tekmira Provides Corporate Update and Announces Third Quarter 2013 Results
Nov 13, 2013
PDF 18.5 KB Add to Briefcase
View Summary Tekmira Announces New Preclinical Data from Anti-Viral Programs
Nov 12, 2013
PDF 15.2 KB Add to Briefcase
Showing 1-20 of 220 Page: 1 2 3 4 5 ... 11  Next 20
Add to Briefcase = add release to Briefcase